JONATHAN IGO: Open Payments
NPI 1215476643 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,509 in 140 payments from 17 companies in 2025. Trend: 2023 $2,603 · 2024 $9,105 · 2025 $4,509
Food & beverage: $2,926Speaker / faculty: $1,250Education: $291Travel & lodging: $42
| Company | Payments | Amount |
|---|---|---|
| Verrica Pharmaceuticals Inc. | 5 | $1,345 |
| Janssen Biotech, Inc. | 20 | $401 |
| GENZYME CORPORATION | 8 | $316 |
| Galderma Laboratories, L.P. | 15 | $305 |
| Arcutis Biotherapeutics, Inc. | 14 | $303 |
| Regeneron Healthcare Solutions, Inc. | 9 | $285 |
| UCB, Inc. | 8 | $278 |
| Incyte Corporation | 11 | $251 |
| ABBVIE INC. | 12 | $243 |
| LEO Pharma Inc. | 15 | $193 |
Products named: YCANTH, DUPIXENT, TREMFYA, Zoryve, NEMLUVIO, Bimzelx, OPZELURA, ADBRY.
Industry payments across CA — which companies pay providers there.
